Yasu Morita to Darbepoetin alfa
This is a "connection" page, showing publications Yasu Morita has written about Darbepoetin alfa.
Connection Strength
0.197
-
Morita Y, Nannya Y, Ichikawa M, Hanamoto H, Shibayama H, Maeda Y, Hata T, Miyamoto T, Kawabata H, Takeuchi K, Tanaka H, Kishimoto J, Miyano S, Matsumura I, Ogawa S, Akashi K, Kanakura Y, Mitani K. ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial. Int J Hematol. 2022 Nov; 116(5):659-668.
Score: 0.197